Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence.

Am J Respir Crit Care Med

Department of Paediatrics, Turku University Central Hospital, University of Turku, Finland.

Published: April 1998

Bacillus Calmette-Guerin (BCG) revaccination was discontinued in Finland in 1990. The objective of this study was to assess the impact of BCG revaccination of tuberculin-negative school-children in prevention of tuberculosis. The tuberculosis cases in 1990-1995 were calculated among age cohorts born 1979-1984 and no longer covered by the BCG revaccination program. Corresponding data were collected for comparison from the period of revaccination in 1980-1985 among age cohorts born in 1969-1974. The National Tuberculosis Register was reviewed in order to observe the tuberculosis trend since 1980 in the age groups of 10-14 and 15-19 yr. Three cases of tuberculosis have been registered among non-BCG-revaccinated children during 6 yr after discontinuation of the program, i.e., 2.23 cases (95% CI 0.72 to 6.90) per million person yr. The control group revealed five cases, 3.78 (95% CI 1.57 to 9.07) per million person yr. The relative risk of tuberculosis in non-BCG-revaccinated children is 0.59 (95% CI 0.14 to 2.47) compared with the control group. The incidence of tuberculosis has continued to decline among adolescents since 1980. The follow-up data confirm that the cessation of BCG revaccination program had no effect on the continuing overall decline of tuberculosis in Finland. The efficacy of BCG revaccination seems to be low or nonexistent in countries with low tuberculosis incidence.

Download full-text PDF

Source
http://dx.doi.org/10.1164/ajrccm.157.4.9706037DOI Listing

Publication Analysis

Top Keywords

bcg revaccination
20
tuberculosis
10
low tuberculosis
8
tuberculosis incidence
8
age cohorts
8
cohorts born
8
revaccination program
8
non-bcg-revaccinated children
8
control group
8
revaccination
7

Similar Publications

BCG's role in strengthening immune responses: Implications for tuberculosis and comorbid diseases.

Infect Genet Evol

December 2024

Department of Life Sciences, Sharda School of Basic Sciences and Research, Sharda University, Knowledge Park III, Greater Noida, Uttar Pradesh 201306, India. Electronic address:

The BCG vaccine represents a significant milestone in the prevention of tuberculosis (TB), particularly in children. Researchers have been developing recombinant BCG (rBCG) variants that can trigger lasting memory responses, thereby enhancing protection against TB in adults. The breakdown of immune surveillance is a key link between TB and other communicable and non-communicable diseases.

View Article and Find Full Text PDF

Early introduction of IL-10 weakens BCG revaccination's protection by suppressing CD4Th1 cell responses.

J Transl Med

December 2024

Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Hubei Key Laboratory of Drug Target Research and Pharmacodynamic Evaluation, Huazhong University of Science and Technology, Wuhan, China.

Article Synopsis
  • The BCG vaccine, the only current vaccine for tuberculosis (TB), shows limited effectiveness in protecting adolescents and adults from active TB, which highlights the need for better understanding of its mechanisms and potential improvements.
  • A study conducted on C57BL/6J mice evaluated the effects of BCG vaccination, particularly analyzing cytokine changes, IL-10 expression across various organs, and the immune response following booster doses.
  • Results indicated that IL-10 levels increased significantly in the lungs and other organs after revaccination, and blocking IL-10 signaling led to enhanced immune responses, suggesting that targeting IL-10 could improve the vaccine's effectiveness against TB.
View Article and Find Full Text PDF
Article Synopsis
  • BCG vaccination is crucial for preventing tuberculosis in children, but Sierra Leone struggles with achieving high and equitable vaccination rates, prompting a study on changes in BCG coverage from 2008 to 2019.
  • The study utilized data from the Sierra Leone Demographic and Health Surveys to analyze inequalities in vaccination rates based on factors like maternal age, education level, economic status, and geographic location.
  • Results showed that overall BCG coverage improved significantly, with increased age-related inequalities and decreased economic-related inequalities, indicating more equitable access to vaccinations among wealthier families, while disparities based on maternal education also declined.
View Article and Find Full Text PDF

Field Trial with Vaccine Candidates Against Bovine Tuberculosis Among Likely Infected Cattle in a Natural Transmission Setting.

Vaccines (Basel)

October 2024

Instituto de Agrobiotecnología y Biología Molecular (IABiMo), UEDD CONICET-INTA, Centro de Investigación en Ciencias Veterinarias y Agronómicas (CICVyA)-CNIA, Hurlingham 1686, Buenos Aires Province, Argentina.

Article Synopsis
  • * In a trial, 74 heifers were vaccinated with different strains and then exposed to naturally infected animals, but the initial vaccination did not produce an adequate immune response, and re-vaccination did not show significant protection against the disease.
  • * The study found a 23% transmission of wild-style strains in non-vaccinated animals, and while some vaccine candidates showed promise in reducing lesions, overall results indicated that further evaluation is needed, as current vaccines did not ensure improved outcomes.
View Article and Find Full Text PDF

The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial.

Lancet Glob Health

November 2024

Immunomodulation and Vaccines Focus Area, Vaccine Research Theme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.

Background: Immune responses induced by several important vaccines differ between populations, with reduced responses in low-income and rural settings compared with high-income and urban settings. BCG immunisation boosts immune responses to some unrelated vaccines in high-income populations. We aimed to test the hypothesis that BCG revaccination can enhance responses to unrelated vaccines in Ugandan schoolchildren.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!